SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

CLDX RSS Feed
Add CLDX Price Alert      Hide Sticky   Hide Intro
Moderator: MrSaintor
Search This Board:
Last Post: 11/23/2016 11:56:50 AM - Followers: 98 - Board type: Free - Posts Today: 0

 

 

 Celldex Therapeutics, Inc. (CLDX)

 

slider-images-2

 slider-images-3
http://www.celldextherapeutics.com
 

 

 
Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
 
CIK
0000744218
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
 
Management: 
http://www.celldextherapeutics.com/about/management.php
 
 
Product Pipeline: 
http://www.celldextherapeutics.com/pipeline/pipeline-overview.php
 
 
News and Press Releases: 
http://ir.celldextherapeutics.com/releases.cfm
 
http://finance.yahoo.com/q/h?s=CLDX+Headlines

 

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 
 
Events and Presentations:
http://ir.celldextherapeutics.com/events.cfm
 
 
SEC Filings:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000744218&owner=exclude&count=40
 
 
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
 
 
Share Structure:
See SEC filings
 
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications
ir@celldextherapeutics.com


----------------------------------------------

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 

yes November 8, 2016  yes

 



http://www.fool.com/investing/2016/11/07/premium-celldex-therapeutics-inc-q3-results.aspx?source=djc&utm_campaign=article&utm_medium=feed&utm_source=djc


From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 

yesyesyesyesyesyesyesyesyesyesyesyesyesyes



--------------------------------------------
 

 
 

 

  


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CLDX News: Small Company Offering and Sale of Securities Without Registration (d) 11/29/2016 04:47:54 PM
CLDX News: Current Report Filing (8-k) 11/29/2016 04:05:21 PM
CLDX News: Celldex Therapeutics Completes Acquisition of Kolltan Pharmaceuticals 11/29/2016 04:01:00 PM
CLDX News: Celldex Presents Data on New Product Candidate, CDX-1140, a Novel CD40 Agonist Antibody 11/14/2016 08:01:00 AM
CLDX News: Quarterly Report (10-q) 11/07/2016 04:40:02 PM
PostSubject
#1330  Sticky Note Celldex Expands Antibody and Immuno-Oncology Portfolio with the MrSaintor 11/07/16 01:14:04 PM
#1370   Let's not forget CDX-011 this could be a REDEMPTIVE 11/23/16 11:56:49 AM
#1369   Healthy Pullback this morning, this thing is a MrSaintor 11/15/16 10:03:04 AM
#1368   Good to have you aboard, exciting times for MrSaintor 11/15/16 09:53:38 AM
#1367   We have held CLDX shares since MEDX days. north40000 11/15/16 08:58:44 AM
#1366   Thanks for the update North, YES huge news MrSaintor 11/14/16 07:14:04 PM
#1365   Attended SITC this past Saturday, 11/12/2016, and talked north40000 11/14/16 04:06:35 PM
#1364   Totally agree, even at these levels great price MrSaintor 11/14/16 02:35:16 PM
#1363   25 harry crumb 11/14/16 02:20:06 PM
#1362   Wow. Good luck to those who held. I erehdogmai 11/14/16 02:09:47 PM
#1361   Any ideas on the pps until year end? Locke1 11/14/16 01:40:14 PM
#1360   Welcome back Locke1 11/14/16 01:36:17 PM
#1359   now thats news, finally for cldx. glad we harry crumb 11/14/16 01:34:10 PM
#1358   Still room to load up, unfortunately I missed Locke1 11/14/16 01:06:59 PM
#1357   With this news and any other breaking news REDEMPTIVE 11/14/16 11:58:28 AM
#1356   Celldex Presents Data on New Product Candidate, CDX-1140, MrSaintor 11/14/16 10:17:12 AM
#1355   LOVE IT .. CDX-1140 !! Great news !! MrSaintor 11/14/16 10:16:24 AM
#1354   Yep oversold and great news last week !! MrSaintor 11/13/16 12:41:52 AM
#1353   Nice little move up this week. It was noretreat 11/11/16 08:49:40 PM
#1352   Buying up the Dips ! MrSaintor 11/11/16 03:17:03 PM
#1351   Celldex looks very promising with its new acquisition MrSaintor 11/11/16 03:16:48 PM
#1350   The whole Bio tech sector will be doing REDEMPTIVE 11/11/16 03:12:51 PM
#1349   This things a beast ! Chart looking good MrSaintor 11/11/16 11:47:24 AM
#1348   Good thing we all don't trade or invest REDEMPTIVE 11/09/16 03:52:45 PM
#1347   Broke $4 ... let's see another push to HallaDurg 11/09/16 10:05:18 AM
#1346   Nice Chart read, clay, thanks for your input. MrSaintor 11/08/16 04:35:06 PM
#1345   And not everyone day trades. This is clearly MrSaintor 11/08/16 04:29:39 PM
#1344   * * $CLDX Video Chart 11-08-16 * * ClayTrader 11/08/16 04:23:37 PM
#1343   Everyones got their own thoughts and strategy's. Moto260 11/08/16 03:29:51 PM
#1342   Shorting this may not be a good idea. REDEMPTIVE 11/08/16 03:22:58 PM
#1341   http://www.fool.com/investing/2016/11/07/premium-celldex-therapeutics-inc-q3-res MrSaintor 11/08/16 11:44:47 AM
#1340   Agreed, this is far from over.. MrSaintor 11/08/16 11:43:31 AM
#1339   WHAT!? News IS GREAT.. You should READ why MrSaintor 11/08/16 11:42:17 AM
#1338   I just didnt feel that news was very Moto260 11/08/16 11:17:43 AM
#1337   Interesting. I will hold for better gains HallaDurg 11/08/16 11:16:10 AM
#1336   Was a good run. I think i'll Moto260 11/08/16 11:00:35 AM
#1335   http://www.investopedia.com/news/celldex-3q-loss-29c-share-tops-street-cldx/?par Moto260 11/08/16 10:59:03 AM
#1334   CLDX on FIRE TODAY !!!!! Vol is insanely MrSaintor 11/08/16 10:54:11 AM
#1333   As predicted, this girl will continue to rise MrSaintor 11/08/16 10:46:39 AM
#1332   Boom time CLDX. Whats the roof on this HallaDurg 11/08/16 10:36:11 AM
#1331   This acquisition is SO HUGE for CLDX .. MrSaintor 11/07/16 10:52:24 PM
#1330   Celldex Expands Antibody and Immuno-Oncology Portfolio with the MrSaintor 11/07/16 01:14:04 PM
#1329   Mod? MrSaintor 11/07/16 12:51:35 PM
#1328   Need to Update news on acquisition .. BIG MrSaintor 11/07/16 12:50:42 PM
#1327   Long on CLDX dip buy MrSaintor 11/07/16 12:49:39 PM
#1326   CLDX pushing up today, volume looking great MrSaintor 11/07/16 12:48:53 PM
#1325   time for cldx to run! chart says its harry crumb 10/26/16 02:48:33 PM
#1324   Whats with the decline from $4.4s ?? HallaDurg 10/14/16 12:49:13 PM
#1323   matter of time for the pps to triple harry crumb 10/10/16 07:46:06 PM
#1322   Good data from phase 2 http://www.celldex.com/science/publications.php#cdx011 MakinBank 10/09/16 09:05:16 AM
#1321   Fill the gaps & reload... easy trader here... erehdogmai 10/07/16 02:22:15 PM
PostSubject